Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
15%
ALSO IN PSIL
PSIL
35
HOLDINGS
31%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PSIL)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 4.7% | 4.7% |
|
ABBVIE INC | 10.3% | 4.5% | 4.5% |
|
JOHNSON & JOHNSON | 6.1% | 4.3% | 4.3% |
 |
ALKERMES PLC | 4.5% | 3.4% | 3.4% |
MEDX Overweight Relative to PSIL
|
ELI LILLY & CO | 14.5% |
 |
NOVARTIS AG-ADR | 6.7% |
|
ABBVIE INC | 5.8% |
|
AMGEN INC | 4.7% |
|
MERCK & CO. INC. | 4.7% |
 |
ASTRAZENECA PLC | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.3% |
|
PFIZER INC | 3.5% |
|
BIOGEN IDEC INC | 3.4% |
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
MEDX Underweight Relative to PSIL
|
DEFINIUM THERAPEUTICS INC | -11.6% |
|
RELMADA THERAPEUTICS INC | -4.7% |
|
NEUROCRINE BIOSCIENCES INC | -4.5% |
|
NEURONETICS, INC. | -4.1% |
|
ALTO NEUROSCIENCE INC | -4.1% |
|
BRIGHT MINDS BIO | -3.7% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
 |
NUMINUS WELLNESS INC | -0.7% |
|
INDIA GLOBALIZATION CAPITAL, INC. | -0.5% |
|
LANTERN PHARMA, INC. | 0.1% |